Trade Mark Journal No.2026/044 30 October 2026

WO0000001943546 (5,9,10,16,42,44)

Office of origin: United States of America

Date of International Registration:12 June 2026
Date of designation in the UK: 12 June 2026
Image for mark 1943546 MIRADX

International priority date claimed: 31 December 2025 (United States of America) (99573201)
Class 5
Specimen collection kits for the collection of saliva for use in DNA screening and genetic testing for medical purposes comprised primarily of swabs with stabilizing reagents for medical purposes.
Class 9
DNA collection kit comprised primarily of DNA collection laboratory swabs and swab handles.
Class 10
Specimen collection kits for use in genetic testing comprised primarily of saliva containers for medical purposes sold empty; medical diagnostic apparatus for testing and analysis of DNA and genetic samples for medical purposes; medical specimen collection devices in the nature of empty tubes and vials for the collection of DNA samples for use in medical testing and analysis of genetics; saliva collection devices for medical purposes; specimen collection kits for the collection of saliva for use in DNA screening and genetic testing for medical purposes comprised primarily of collection tubes with caps, with or without stabilizing reagents.
Class 16
Printed instructions, printed mailing labels, and flat pack cardboard mailing boxes; printed instructions, printed mailing labels and flat pack cardboard mailing boxes for the collection of saliva for use in DNA screening and genetic testing for medical purposes.
Class 42
Medical testing for predicting toxicity and response in connection with cancer treatments; medical risk assessment services in the nature of predicting toxicity and response in connection with cancer treatments.
Class 44
Medical and laboratory analysis in connection with the treatment of patients; medical laboratory services for the analysis of samples taken from patients, namely processing medical test kits and home sample collection kits for diagnostic and treatment purposes; medical testing of saliva and blood; medical testing for diagnostic or treatment purposes; genetic testing for medical purposes; medical consultancy services.

Mira DX, Inc.

Representative: Jessica L. Rothstein GOODWIN PROCTER LLP, 620 Eighth Avenue, New York NY 10018, UNITED STATES OF AMERICA